Demetrix is a biotechnology company that produces rare cannabinoids using fermentation technology. The company was founded in 2015 by Jay Keasling, a professor of chemical engineering and bioengineering at the University of California, Berkeley. Demetrix's technology allows for the production of rare cannabinoids in a more sustainable and cost-effective manner than traditional methods. The company's goal is to make rare cannabinoids more accessible for research and development, as well as for use in consumer products such as pharmaceuticals, food, and cosmetics.